Frontier Biotechnologies Inc. Class ASSE: 688221

Announcement on the Signing of an Authorization and License Agreement with GSK

· Issued by Frontier Biotechnologies Inc. Class A via Shanghai Stock Exchange
Announcement on the Signing of an Authorization and License Agreement with GSK

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment